Liquidia Corp (LQDA)

$32.74 -0.85 (-2.53%)
Market Cap 2.92B
Revenue (ttm) 14.00M
Net Income (ttm) -130.39M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE 54.13
Profit Margin -931.36%
Debt to Equity Ratio 8.73
Volume 2,255,900
Avg Vol 1,806,686
Day's Range N/A - N/A
Shares Out 87.00M
Stochastic %K 12%
Beta 0.46
Analysts Strong Sell
Price Target $43.00

Company Profile

Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). The company also offers Remodulin, a treprostinil administered through continuous intravenous and subcutaneou...

Industry: Biotechnology
Sector: Healthcare
Phone: 919 328 4400
Fax: 919 328 4402
Address:
419 Davis Drive, Suite 100, Morrisville, United States
jlonards
jlonards Feb. 24 at 5:17 AM
$LQDA ooops
0 · Reply
Hamboning
Hamboning Feb. 24 at 1:10 AM
$LQDA This is by far my favorite stock of all time. Literally every single day I can count on the stock being red and my puts printing more and more. Easiest money I’ve ever made in the stock market. Looking forward to the sell offs this week
0 · Reply
Gambaa
Gambaa Feb. 23 at 8:00 PM
$LQDA https://x.com/bdc_analyst/status/2025988166520647682?s=46&t=XpQsAPGJtIU5DcxtMNKtOg
0 · Reply
Hamboning
Hamboning Feb. 23 at 5:52 PM
$LQDA I don’t see this sell off ending until the stock is in the low 10s. Can’t wait to see how much my puts are worth when that happens 😮‍💨
0 · Reply
Doom_Gloom_AR
Doom_Gloom_AR Feb. 23 at 5:35 PM
$LQDA I'm not sure what your short thesis is here? anyone care to explain?
2 · Reply
Gambaa
Gambaa Feb. 23 at 3:35 PM
$GOSS rip, great news for $LQDA the real winner in this space 💪
1 · Reply
dayfornight99
dayfornight99 Feb. 23 at 3:27 PM
$LQDA Does this have an earnings date yet?
0 · Reply
CrispDry
CrispDry Feb. 23 at 1:21 PM
$GOSS good for $LQDA
0 · Reply
Hamboning
Hamboning Feb. 23 at 5:04 AM
$LQDA
0 · Reply
SuperGreenToday
SuperGreenToday Feb. 21 at 10:07 PM
$LQDA Share Price: $33.61 Contract Selected: Mar 20, 2026 $35 Calls Buy Zone: $4.17 – $5.15 Target Zone: $6.65 – $8.13 Potential Upside: 51% ROI Time to Expiration: 26 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
Latest News on LQDA
Liquidia Corporation (LQDA) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Jan 14, 2026, 10:25 PM EST - 5 weeks ago

Liquidia Corporation (LQDA) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Liquidia: Yutrepia's Attributes In Focus, But Binary Risk Shouldn't Be Ignored

Jan 8, 2026, 2:00 PM EST - 6 weeks ago

Liquidia: Yutrepia's Attributes In Focus, But Binary Risk Shouldn't Be Ignored

Liquidia Corporation (LQDA) Presents at Jefferies London Healthcare Conference 2025 Transcript

Nov 19, 2025, 2:38 AM EST - 3 months ago

Liquidia Corporation (LQDA) Presents at Jefferies London Healthcare Conference 2025 Transcript

Liquidia Corporation: Heading In The Right Direction

Nov 5, 2025, 6:16 PM EST - 3 months ago

Liquidia Corporation: Heading In The Right Direction

Liquidia Corporation (LQDA) Q3 2025 Earnings Call Transcript

Nov 3, 2025, 12:16 PM EST - 4 months ago

Liquidia Corporation (LQDA) Q3 2025 Earnings Call Transcript

Liquidia Corporation to Present at Upcoming Healthcare Investment Conferences

Nov 3, 2025, 8:00 AM EST - 4 months ago

Liquidia Corporation to Present at Upcoming Healthcare Investment Conferences

Liquidia Corporation (LQDA) Discusses Innovations in Inhaled Treprostinil Therapies and Updates on Drug Delivery Technologies Transcript

Oct 29, 2025, 2:46 PM EDT - 4 months ago

Liquidia Corporation (LQDA) Discusses Innovations in Inhaled Treprostinil Therapies and Updates on Drug Delivery Technologies Transcript

Liquidia Corporation to Report Third Quarter 2025 Financial Results on November 3, 2025

Oct 27, 2025, 8:30 AM EDT - 4 months ago

Liquidia Corporation to Report Third Quarter 2025 Financial Results on November 3, 2025

Liquidia Corporation to Host R&D Day in New York City on October 28, 2025

Oct 7, 2025, 6:30 AM EDT - 4 months ago

Liquidia Corporation to Host R&D Day in New York City on October 28, 2025

Liquidia Corporation to Present at the 2025 Wells Fargo Healthcare Conference

Aug 27, 2025, 8:30 AM EDT - 6 months ago

Liquidia Corporation to Present at the 2025 Wells Fargo Healthcare Conference

Liquidia Analysts Raise Their Forecasts Following Q2 Results

Aug 13, 2025, 2:51 PM EDT - 6 months ago

Liquidia Analysts Raise Their Forecasts Following Q2 Results

Why Is Liquidia Stock Trading Higher On Tuesday?

Aug 12, 2025, 2:25 PM EDT - 6 months ago

Why Is Liquidia Stock Trading Higher On Tuesday?

Liquidia Corporation (LQDA) Q2 2025 Earnings Call Transcript

Aug 12, 2025, 12:43 PM EDT - 6 months ago

Liquidia Corporation (LQDA) Q2 2025 Earnings Call Transcript

Liquidia Corporation Reports Second Quarter 2025 Financial Results and Provides Corporate Update

Aug 12, 2025, 6:30 AM EDT - 6 months ago

Liquidia Corporation Reports Second Quarter 2025 Financial Results and Provides Corporate Update

What Next For Liquidia After Launch?

Jun 30, 2025, 10:40 AM EDT - 8 months ago

What Next For Liquidia After Launch?

Liquidia Receives $50 Million from Healthcare Royalty (HCRx) Following First Commercial Sale of YUTREPIA™

Jun 23, 2025, 4:34 PM EDT - 8 months ago

Liquidia Receives $50 Million from Healthcare Royalty (HCRx) Following First Commercial Sale of YUTREPIA™

Liquidia Schedules First Commercial Shipment of YUTREPIA™ (treprostinil) Inhalation Powder for Patients with PAH and PH-ILD

Jun 2, 2025, 6:30 AM EDT - 9 months ago

Liquidia Schedules First Commercial Shipment of YUTREPIA™ (treprostinil) Inhalation Powder for Patients with PAH and PH-ILD

These Analysts Boost Their Forecasts On Liquidia

May 28, 2025, 11:08 AM EDT - 9 months ago

These Analysts Boost Their Forecasts On Liquidia

Liquidia Corporation to Present at the 2025 Jefferies Global Healthcare Conference

May 28, 2025, 8:00 AM EDT - 9 months ago

Liquidia Corporation to Present at the 2025 Jefferies Global Healthcare Conference

U.S. FDA Approves Liquidia's YUTREPIA™ (treprostinil) Inhalation Powder for Patients with Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD)

May 23, 2025, 2:28 PM EDT - 9 months ago

U.S. FDA Approves Liquidia's YUTREPIA™ (treprostinil) Inhalation Powder for Patients with Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD)

Liquidia Corporation Provides Update on Litigation Filed by United Therapeutics

May 12, 2025, 6:00 AM EDT - 10 months ago

Liquidia Corporation Provides Update on Litigation Filed by United Therapeutics

Liquidia Corporation (LQDA) Q1 2025 Earnings Call Transcript

May 10, 2025, 9:29 PM EDT - 10 months ago

Liquidia Corporation (LQDA) Q1 2025 Earnings Call Transcript

Liquidia Corporation Reports First Quarter 2025 Financial Results and Provides Corporate Update

May 8, 2025, 6:30 AM EDT - 10 months ago

Liquidia Corporation Reports First Quarter 2025 Financial Results and Provides Corporate Update

Liquidia Corporation: A Strong Buy On High Likelihood Of FDA Approval This Month

May 5, 2025, 4:06 PM EDT - 10 months ago

Liquidia Corporation: A Strong Buy On High Likelihood Of FDA Approval This Month

District Court Dismisses Dispute Filed by United Therapeutics Against Liquidia

May 2, 2025, 5:28 PM EDT - 10 months ago

District Court Dismisses Dispute Filed by United Therapeutics Against Liquidia

Liquidia Corporation to Report First Quarter 2025 Financial Results on May 8, 2025

May 1, 2025, 8:00 AM EDT - 10 months ago

Liquidia Corporation to Report First Quarter 2025 Financial Results on May 8, 2025

Arquitos Capital's Largest Holdings  For Q1 2025

Apr 30, 2025, 9:30 AM EDT - 10 months ago

Arquitos Capital's Largest Holdings  For Q1 2025

UPDATE – Liquidia Corporation to Present at the 24th Annual Needham Virtual Healthcare Conference

Apr 1, 2025, 10:33 AM EDT - 11 months ago

UPDATE – Liquidia Corporation to Present at the 24th Annual Needham Virtual Healthcare Conference

Liquidia Corporation to Present at the 24th Annual Needham Virtual Healthcare Conference

Apr 1, 2025, 8:00 AM EDT - 11 months ago

Liquidia Corporation to Present at the 24th Annual Needham Virtual Healthcare Conference

Liquidia Corporation Announces FDA Acceptance of New Drug Application Resubmission for YUTREPIA™ (treprostinil) Inhalation Powder

Mar 28, 2025, 9:30 AM EDT - 11 months ago

Liquidia Corporation Announces FDA Acceptance of New Drug Application Resubmission for YUTREPIA™ (treprostinil) Inhalation Powder

Liquidia Corporation (LQDA) Q4 2024 Earnings Call Transcript

Mar 19, 2025, 11:56 AM EDT - 1 year ago

Liquidia Corporation (LQDA) Q4 2024 Earnings Call Transcript

Liquidia Corporation Reports Full Year 2024 Financial Results and Provides Corporate Update

Mar 19, 2025, 6:30 AM EDT - 1 year ago

Liquidia Corporation Reports Full Year 2024 Financial Results and Provides Corporate Update

Liquidia Corporation to Report Full Year 2024 Financial Results on March 19, 2025

Mar 12, 2025, 8:00 AM EDT - 1 year ago

Liquidia Corporation to Report Full Year 2024 Financial Results on March 19, 2025

Liquidia Corporation: Resilience In The Face Of Formidable Opposition Can Pay Off

Nov 15, 2024, 10:20 AM EST - 1 year ago

Liquidia Corporation: Resilience In The Face Of Formidable Opposition Can Pay Off

Liquidia Corporation (LQDA) Q3 2024 Earnings Call Transcript

Nov 13, 2024, 2:40 PM EST - 1 year ago

Liquidia Corporation (LQDA) Q3 2024 Earnings Call Transcript

Liquidia Corporation Reports Third Quarter 2024 Financial Results and Provides Corporate Update

Nov 13, 2024, 6:30 AM EST - 1 year ago

Liquidia Corporation Reports Third Quarter 2024 Financial Results and Provides Corporate Update

United States Supreme Court Declines to Review Rulings that Invalidate United Therapeutics' Patent

Oct 7, 2024, 10:00 AM EDT - 1 year ago

United States Supreme Court Declines to Review Rulings that Invalidate United Therapeutics' Patent

Liquidia and Pharmosa Biopharm Expand Collaboration to Develop Sustained Release Inhaled Treprostinil (L606)

Oct 2, 2024, 6:00 AM EDT - 1 year ago

Liquidia and Pharmosa Biopharm Expand Collaboration to Develop Sustained Release Inhaled Treprostinil (L606)

Liquidia Corporation Is Being Sued For Violating Securities Laws And Affected Investors Are Invited To Help The Schall Law Firm

Oct 1, 2024, 11:00 AM EDT - 1 year ago

Liquidia Corporation Is Being Sued For Violating Securities Laws And Affected Investors Are Invited To Help The Schall Law Firm

Liquidia Corporation Is Being Investigated For Violating Securities Laws And Impacted Investors Are Encouraged To Contact The Schall Law Firm

Sep 30, 2024, 11:00 AM EDT - 1 year ago

Liquidia Corporation Is Being Investigated For Violating Securities Laws And Impacted Investors Are Encouraged To Contact The Schall Law Firm

Liquidia Announces Poster Presentation and Medical Theater at the CHEST 2024 Annual Meeting

Sep 30, 2024, 8:00 AM EDT - 1 year ago

Liquidia Announces Poster Presentation and Medical Theater at the CHEST 2024 Annual Meeting

The Schall Law Firm Urges Shareholder Participation In A Securities Fraud Inquiry Into Liquidia Corporation

Sep 29, 2024, 11:00 AM EDT - 1 year ago

The Schall Law Firm Urges Shareholder Participation In A Securities Fraud Inquiry Into Liquidia Corporation

Liquidia Corporation Is Being Investigated For Violating Securities Laws And Investors Are Invited To Contact The Schall Law Firm

Sep 28, 2024, 11:00 AM EDT - 1 year ago

Liquidia Corporation Is Being Investigated For Violating Securities Laws And Investors Are Invited To Contact The Schall Law Firm

Investors Are Invited To Help The Schall Law Firm Investigate Whether Liquidia Corporation Violated Securities Laws

Sep 24, 2024, 11:00 AM EDT - 1 year ago

Investors Are Invited To Help The Schall Law Firm Investigate Whether Liquidia Corporation Violated Securities Laws

The Schall Law Firm Is Looking Into Liquidia Corporation For Securities Fraud And Shareholders With Losses Should Reach Out

Sep 23, 2024, 11:00 AM EDT - 1 year ago

The Schall Law Firm Is Looking Into Liquidia Corporation For Securities Fraud And Shareholders With Losses Should Reach Out

Liquidia Corporation May Have Defrauded The Public And The Schall Law Firm Wants Shareholders With Losses To Reach Out

Sep 21, 2024, 11:00 AM EDT - 1 year ago

Liquidia Corporation May Have Defrauded The Public And The Schall Law Firm Wants Shareholders With Losses To Reach Out

The Schall Law Firm Has Launched An Inquiry Into Liquidia Corporation For Violating Securities Laws And Affected Investors Should Participate

Sep 20, 2024, 11:00 AM EDT - 1 year ago

The Schall Law Firm Has Launched An Inquiry Into Liquidia Corporation For Violating Securities Laws And Affected Investors Should Participate

jlonards
jlonards Feb. 24 at 5:17 AM
$LQDA ooops
0 · Reply
Hamboning
Hamboning Feb. 24 at 1:10 AM
$LQDA This is by far my favorite stock of all time. Literally every single day I can count on the stock being red and my puts printing more and more. Easiest money I’ve ever made in the stock market. Looking forward to the sell offs this week
0 · Reply
Gambaa
Gambaa Feb. 23 at 8:00 PM
$LQDA https://x.com/bdc_analyst/status/2025988166520647682?s=46&t=XpQsAPGJtIU5DcxtMNKtOg
0 · Reply
Hamboning
Hamboning Feb. 23 at 5:52 PM
$LQDA I don’t see this sell off ending until the stock is in the low 10s. Can’t wait to see how much my puts are worth when that happens 😮‍💨
0 · Reply
Doom_Gloom_AR
Doom_Gloom_AR Feb. 23 at 5:35 PM
$LQDA I'm not sure what your short thesis is here? anyone care to explain?
2 · Reply
Gambaa
Gambaa Feb. 23 at 3:35 PM
$GOSS rip, great news for $LQDA the real winner in this space 💪
1 · Reply
dayfornight99
dayfornight99 Feb. 23 at 3:27 PM
$LQDA Does this have an earnings date yet?
0 · Reply
CrispDry
CrispDry Feb. 23 at 1:21 PM
$GOSS good for $LQDA
0 · Reply
Hamboning
Hamboning Feb. 23 at 5:04 AM
$LQDA
0 · Reply
SuperGreenToday
SuperGreenToday Feb. 21 at 10:07 PM
$LQDA Share Price: $33.61 Contract Selected: Mar 20, 2026 $35 Calls Buy Zone: $4.17 – $5.15 Target Zone: $6.65 – $8.13 Potential Upside: 51% ROI Time to Expiration: 26 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
Gambaa
Gambaa Feb. 21 at 4:08 AM
$LQDA we will have our day!
0 · Reply
clan
clan Feb. 20 at 11:31 PM
$LQDA If you know, you know. I knew. Yutrepia causes its users to 💩 their 👖! @stevemano
0 · Reply
Hamboning
Hamboning Feb. 20 at 7:22 PM
$LQDA Im not sure how anybody who loves making money chooses not to buy puts on this stock. I’ve been preaching it for days now, puts here are simply free money. And they’ll continue to be free money.
1 · Reply
MayorofMNKD
MayorofMNKD Feb. 20 at 6:05 PM
$LQDA … why does this keep bleeding?
0 · Reply
Ms_P
Ms_P Feb. 20 at 3:37 PM
$LQDA People really believing that judge is going to rule against LQDA. Likely positive news is out before earnings. https://x.com/alphahunte79332/status/2022392048070885700?s=46
0 · Reply
stevemano
stevemano Feb. 20 at 2:36 PM
$LQDA The big short
0 · Reply
Ceherring
Ceherring Feb. 20 at 11:40 AM
$LQDA
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Feb. 19 at 6:37 PM
$LQDA RSI: 31.35, MACD: -0.4245 Vol: 3.31, MA20: 40.88, MA50: 37.31 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
ChartBandit02
ChartBandit02 Feb. 18 at 11:44 PM
$LQDA anyone got anything on the new trial or court stuff
1 · Reply
BullRun4
BullRun4 Feb. 18 at 11:21 PM
$LQDA Super bullish going into March!!
0 · Reply
BDE_Worldwide
BDE_Worldwide Feb. 18 at 8:52 PM
$LQDA interesting call volume for the 2/20’s.. expiring in a few days.. Judge’s ruling could come down at anytime..
1 · Reply
VolumeChaser
VolumeChaser Feb. 18 at 9:24 AM
$LQDA Pulmonary-focused biotech with binary trial outcomes; risk management is essential.
1 · Reply